8legs: Cleveland clinic

Your Followed Topics

#1 out of 3

health53m ago

New study links GLP-1 weight-loss drugs to slower cancer progression in several obesity-related cancers.
Study followed 12,112 patients and compared GLP-1 drugs with DPP-4 inhibitors.
GLP-1 users had lower progression to stage 4 cancer for four solid tumor types, especially NSCLC and breast cancer.
Researchers caution the findings are not proof of causation due to the observational design.
Tumors with higher GLP-1 receptor levels showed better survival outcomes in the study.
Researchers call for randomized trials to confirm how GLP-1 pathways affect cancer growth.
Adverse side effects were similar between GLP-1 and gliptin groups in the study.
Study authors note potential confounders like weight loss and metabolic changes could influence results.
The research was presented at a major medical conference and not yet peer-reviewed.
The report highlights GLP-1 pathways may directly influence cancer growth or spread.

Vote 0

#2 out of 321.74%

Doctors confirm myositis as an autoimmune condition and highlight remission as an achievable goal with proper care.
The care team may add tests like lung function, imaging, swallowing studies, and cancer screenings.
Corticosteroids are usually the first treatment to calm inflammation, with steroid-sparing options considered long term.
Immunosuppressants and IVIG may be used to balance the immune system while limiting infections.
Physical therapy is a cornerstone of care to rebuild strength and improve daily function.
A multidisciplinary team helps address the diverse effects of myositis on mobility, swallowing, skin, lungs, and more.
A Mediterranean-style anti-inflammatory diet may support overall health during myositis management.
Mental health support is encouraged as part of managing the emotional impact of the condition.
Ongoing follow-up is advised to monitor strength, symptoms, medications, and lung function.
Patients should report new or worsening symptoms promptly to maintain control of the disease.

Vote 0

#3 out of 3

Cleveland Clinic and the PGA TOUR have formed a multi-year partnership to make performance insights central to player care across the season.
The Global Peak Performance Center is set to open in 2027 and will centralize testing, nutrition, and recovery under one roof.
The center will integrate motion-capture, force plates, and physiology evaluation to streamline care for athletes at all levels.
Cleveland Clinic intends to use artificial intelligence to derive performance insights that can improve care for both pro athletes and the general public.
The PGA TOUR partnership will provide players with on-site and travel-based health services and access to performance tools grounded in current evidence.
The center will serve not only professional athletes but also the general public, offering high-tech testing and multidisciplinary care.
The Center will host a team of specialists including clinicians, nutritionists, biomechanists, and physical therapists to pursue a multidisciplinary approach.
The initiative aims to translate performance insights into care improvements for a wide range of populations beyond athletes.
Cleveland Clinic notes international collaboration, with input from London, Florida, and Abu Dhabi experts to inform global best practices.

Vote 0

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.